Status:

UNKNOWN

Prevalence of Peripheral Neuropathy Among Patients With Auditory Neuropathy

Lead Sponsor:

Sohag University

Conditions:

Auditory Neuropathy Spectrum Disorder,, Peripheral Neuropathy

Eligibility:

All Genders

12-60 years

Brief Summary

Auditory neuropathy/ dys-synchrony/ peri-synaptic audiopathy (AN) are terms used to describe a specific hearing disorder with a disturbed auditory neural response in presence of normal cochlear functi...

Eligibility Criteria

Inclusion

  • Age ranges from 12 to 50 years old.
  • Disproportionate speech recognition score (SRS) with the hearing threshold level.
  • The auditory brainstem response (ABR) test with no waveform or, disturbed waves or, detectable wave V at high intense stimulus.
  • The otoacoustic emission (OAE) and/or cochlear microphonic (CM) potential may be present.

Exclusion

  • While the participants who have these criteria will be excluded from the study:
  • Consistent SRS and ABR response with hearing threshold level.
  • Abnormal finding in brain imaging.
  • Patients with history of diabetes and/or other causes of peripheral neuropathy

Key Trial Info

Start Date :

August 1 2023

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

August 1 2024

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT06041360

Start Date

August 1 2023

End Date

August 1 2024

Last Update

September 18 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Sohag university Hospital

Sohag, Egypt